Distribution Collaboration between 2BScientific and Shenzhen Sekbio
Aiming for the same goal to fight the coronavirus disease, 2BScientific will distribute Shenzhen Sekbio COVID-19 product (antigen and antibodies) into the UK market through its massive distribution channel.
COLLABORATIONON
COVID-19 PRODUCT
Aiming for the same goal to fight the coronavirus disease, 2bscientific will distribute Shenzhen Sekbio COVID-19 product ( antigen and antibodies ) into the UK market through its massive distribution channel.
About 2bscientific
With its headquarters in Oxfordshire, UK, 2bscientific is reinventing the supply of immunological reagents and kits to the European research market. At the heart of everything we do lies our mission statement: 2bscientific Ltd s mission is to become the leading supplier of innovative life science reagents and services to the European research market.
About Shenzhen Sekbio Co Ltd
SHENZHEN SEKBO Co. Ltd located in Shenzhen, China who is a privately-held biotech manufacturer Shenzhen is the innovation center of China now And innovation is in our blood. We are dedicated to developing the highest quality VD raw material, semi-finished reagent solution for our customers. Our superior quality products like Antigens and antibodies are an outcome of several years of research work by world-renowned scientists.
Contacted: sales@sekbio.com
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics